Autolus Therapeutics (AUTL) EPS (Basic) (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly EPS (Basic) came in at -$0.34 in Q4 2025, down 213.82% YoY from $0.3 in Q4 2024, and down 14.21% on a QoQ basis from -$0.3 in Q3 2025.
Powered by 
Analysis
Autolus Therapeutics (AUTL) EPS (Basic) (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of EPS (Basic) data on file, last reported at -$0.34 in Q4 2025.
- Quarterly EPS (Basic) fell 213.82% year-over-year to -$0.34 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.08 (down 24.94% YoY) and the FY2025 annual result came in at -$1.08, down 24.94% from the prior year.
- EPS (Basic) slipped to -$0.34 in Q4 2025, from -$0.3 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.11 in Q4 2024 to a low of -$0.58 in Q4 2021.
- A 5-year average of -$0.34 and a median of -$0.3 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) jumped 75.61% — and 2025, when it plunged 213.82%.
- Tracing AUTL's EPS (Basic) over 5 years: stood at -$0.58 in 2021, then soared by 50.91% to -$0.28 in 2022, then tumbled by 56.21% to -$0.44 in 2023, then jumped by 75.61% to -$0.11 in 2024, then sank by 213.82% to -$0.34 in 2025.
- The last three EPS (Basic) figures came in at -$0.34 (Q4 2025), -$0.3 (Q3 2025), and -$0.18 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Autolus Therapeutics | 594.86 Mn | 393.23 Mn | 25.22 Mn | -0.15 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.15 |
| Dec 31, 2025 | -0.34 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.26 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -0.22 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.44 |
| Sep 30, 2023 | -0.26 |
| Jun 30, 2023 | -0.26 |
| Mar 31, 2023 | -0.23 |
| Dec 31, 2022 | -0.28 |
| Sep 30, 2022 | -0.47 |
| Jun 30, 2022 | -0.46 |
| Mar 31, 2022 | -0.41 |
| Dec 31, 2021 | -0.58 |
| Sep 30, 2021 | -0.66 |
| Jun 30, 2021 | -0.64 |